Are you interested in higher yield and a better safety profile for your mRNA and AAV plasmid templates?

Discover the Power of Small. The Nanoplasmid^TM platform is a next-generation small cloning backbone (<500) with a patented antibiotic-free selection system offering significant benefits in numerous cell and gene-based applications.  

Nanoplasmid Benefits: 

• Improved plasmid manufacturing (>1g/L) 
• PolyA tail stabilization for mRNA production 
• ITR repeat stabilization for AAV production  
• Eliminates antibiotic resistance gene transfer  
• Traditional plasmid retrofitting   

Conventional mRNA expression vectors were compared to vectors retrofitted into the Nanoplasmid vector. For an AAV and other platform examples click here.

Nanoplasmid, a next-generation plasmid, has been featured in many published studies and utilized in clinical trials. The Aldevron team can help you design and build a new construct or retrofit an existing traditional plasmid.